Effect of NAPDH oxidase inhibitors on lung fibroblast proliferation in systemic sclerosis

T. Hua-Huy (Paris, France), C. Nicco (Paris, France), J. Boucher (Paris, France), H. Vu-Ngoc (Paris, France), E. Tran-Van-Hoi (Paris, France), F. Batteux (Paris, France), A. Slama-Schwok (Jouy en Josas, France), A. Dinh-Xuan (Paris, France)

Source: International Congress 2018 – Pulmonary fibrosis: from models to patients
Session: Pulmonary fibrosis: from models to patients
Session type: Thematic Poster
Number: 992
Disease area: Interstitial lung diseases

Congress or journal article abstractSlide presentation

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
T. Hua-Huy (Paris, France), C. Nicco (Paris, France), J. Boucher (Paris, France), H. Vu-Ngoc (Paris, France), E. Tran-Van-Hoi (Paris, France), F. Batteux (Paris, France), A. Slama-Schwok (Jouy en Josas, France), A. Dinh-Xuan (Paris, France). Effect of NAPDH oxidase inhibitors on lung fibroblast proliferation in systemic sclerosis. 992

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you: